Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Radiopharmaceutical Pluvicto, Locametz, Lutathera and…

U.S. Department Of Defense·California

Radiopharmaceutical Pluvicto, Locametz, Lutathera and Netspot Injections

Closes 12/9/2025$5M – $50MSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Defense Health Agency Contracting Activity (DHACA) intends to award a firm fixed price 5 Year Blanket Purchase Agreement for Radiopharmaceutical Pluvicto, Locametz, Lutathera and Netspot Injections. The contract will be used to procure injections for the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). The required injections are for emergency treatments. The following products are included: • PLUVICTO injection for intravenous use • LOCAMETZ injection for intravenous use • LUTATHERA injection for intravenous use • NETSPOT injection for intravenous use The period of performance is from 5 January 2026 to 4 January 2031.

Attached files

Contact

Cha-on P. Gordon

[email protected]

(726) 203-0109

Key dates

Opened
11/19/2025
Closes
12/9/2025
Duration
5 years

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
325412
Solicitation №
HT941026N0009

Budget estimate

$5,000,000 – $50,000,000

The budget for this contract can be estimated based on the type and quantity of radiopharmaceutical injections required. Since the notice of intent does not provide a specific quantity or payment amount, it is difficult to determine an exact budget. However, the contract is for a 5-year period, and the products are for emergency treatments, which suggests a potentially high budget. The budget could be influenced by factors such as the number of medical treatment facilities, the frequency of emergency treatments, and the cost of the radiopharmaceutical injections. A rough estimate could be in the range of $1 million to $10 million per year, depending on the above factors.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Veterans Affairs·Pennsylvania

Top match · 72%

6505--INTENT TO SOLE SOURCE Radiopharm - Lutathera & Pluvicto - Lebanon VAMC

Closes 11/3/2026Opened 10/29/2026

U.S. Department Of Energy·Ohio

66% match

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

Closes 12/3/2026Opened 6/4/2026

U.S. Department Of Veterans Affairs·Ohio

64% match

6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052

Closes 11/3/2026Opened 10/19/2026

U.S. National Institutes of Health·United States of America

63% match

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Closes 1/15/2027Opened 9/18/2024

U.S. Food and Drug Administration·United States of America

63% match

Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

Rolling / TBD closeOpened 11/21/2023

U.S. National Institutes of Health·United States of America

63% match

Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)

Closes 11/10/2026Opened 3/3/2026

U.S. National Institutes of Health·United States of America

63% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. Department Of Defense·Pennsylvania

62% match

Epinephrine Injector

Closes 11/2/2026Opened 4/29/2026

City of Tulsa·Oklahoma

62% match

Drug Testing Lab Services

Closes 11/4/2026Opened 10/10/2026

U.S. Department Of Defense·Pennsylvania

62% match

Atropine Auto-Injector

Closes 11/30/2026Opened 10/29/2026

Massachusetts Department of Public Health·Massachusetts

62% match

RFR 248431 Medical instrument and implants

Closes 6/29/2031Opened 2/2/2024

U.S. Department Of Defense·Massachusetts

62% match

Individual Water Treatment Device (IWTD) Laboratory Testing

Closes 11/12/2026Opened 10/8/2026

U.S. Department Of Defense·United States of America

62% match

Tolterodine Tartrate ER 24HR Capsules

Closes 12/12/2029Opened 11/21/2022

U.S. National Institutes of Health·United States of America

62% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. National Institutes of Health·United States of America

62% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

62% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

New York City Department of Health and Mental Hygiene·New York

61% match

81627Y0875-Purchase of Raboravel V-RG Vaccines

Closes 11/9/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

61% match

Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)

Closes 1/9/2029Opened 6/9/2025

U.S. Department Of Defense·Indiana

61% match

Pantoprazole DR Tablets

Closes 1/26/2028Opened 6/10/2021

U.S. National Institutes of Health·United States of America

61% match

NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

Closes 12/1/2030Opened 2/27/2026

Massachusetts Department of Public Health·Massachusetts

61% match

RFR_185127 Diagnostic Imaging Supplies

Closes 9/30/2027Opened 8/14/2017

U.S. National Institutes of Health·United States of America

61% match

A Holistic Approach to Study Non-Addictive Natural Products for Pain Management

Closes 5/24/2027Opened 4/22/2026

U.S. Department Of Defense·Maryland

61% match

Request for Information – Prophylactic Platform for Medical Countermeasures

Closes 11/18/2026Opened 10/19/2026

U.S. National Institutes of Health·United States of America

61% match

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closes 2/20/2029Opened 5/28/2025

U.S. Department Of Health And Human Services·Maryland

61% match

Reagents and consumables for Roche immunostainers

Closes 11/16/2026Opened 10/30/2026